If medicine is a science and based on facts and research, why do physicians disagree? The difficulty—and often uncertainty—surrounding medical decision-making was the topic of Sunday morning’s ATS Lecture Keynote Series.

Since 1969, the National Institutes of Health’s Division of Lung Diseases (DLD) has facilitated the development of a robust and vibrant research community, which has produced research findings that have changed practice.

Effective ways of teaching and disseminating knowledge have changed rapidly. The current climate of fast, ready-to-go access to information has altered how learners interact with content, and adult learning theories have changed the way content is delivered.

Successful completion of critical care trials is fraught with barriers. These barriers may include engaging with surrogates, as patients often cannot consent. Patients’ health can quickly take a turn for the worse and eliminate them from trials, resulting in missing data.

Recognition Awards for Scientific Accomplishments are presented each year to four scientists to recognize outstanding scientific contributions in basic or clinical research that enhance the understanding, prevention, and treatment of respiratory disease or critical illness.

Three early career investigators are vying for a $10,000 cash prize during the ATS BEAR Cage competition on Monday afternoon. Each will “pitch” his or her proposal to a panel of translational science experts, which will ultimately select the winner.

Michael DeBaun, MD, MPH, the keynote at Saturday’s ATS Diversity Forum, has a list of accolades. At 59, he has the freedom to look back and advise the next generation of leaders about what diversity means in the medical community.

The FDA has recently approved two minimally invasive endobronchial valves (EBV) that mimic the effects of LVRS and can be placed endoscopically as a new option for these patients.

Student Scholars Program participants received a crash course in nonprofits in the lung disease community at Saturday’s PAR Path.

The ATS Keynote Series continues today as speakers explore the mysteries of breathlessness in COPD and data sharing in the context of clinical trials.